Recent Updates
Recently added Catalysts
IMMP

Rule 2.7, 3.10.3, 3.10.4, 3.10.5 Appendix 3B New Issue Announcement, Application for Quotation of Additional Securities and Agreement Information or documents not available now must be given to ASX as soon as available.

Key Takeaway: Rule 2.7, 3.10.3, 3.10.4, 3.10.5 New Issue Announcement, Application for Quotation of Additional Securities and Agreement Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX s property and ma

Full Press Release Details

Rule 2.7, 3.10.3, 3.10.4, 3.10.5
New Issue Announcement,
Application for Quotation of Additional
Securities and Agreement
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become
ASX s property and may be made public.
Introduced 1/7/96. Origin: Appendix 5. Amended 1/7/98, 1/9/99, 1/7/2000, 30/9/2001,
11/3/2002, 1/1/2003, 24/10/2005.
Name of Entity:
Prima BioMed Ltd (ASX: PRR)
ABN:
90 009 237 889
We (the entity) give ASX the following information.
You must complete the relevant sections (attach sheets if there is
1 + Class of + securities issued or to be issued Unlisted Options (PRRAL)
2 Number of + securities issued or to be issued (if known) or maximum number which may be issued 1,600,000
3 Principal terms of the + securities (eg, if options, exercise price and expiry date; if partly paid + securities, the amount outstanding and due dates for payment; if + convertible securities, the conversion price and dates for conversion) Exercise price of $0.185 on or before 1 August 2015
4 Do the + securities rank equally in all respects from the date of allotment with an existing + class of quoted + securities? If the additional securities do not rank equally, please state: the date from which they do the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment Yes on exercise of options
5 Issue price or consideration Employees services
6 Purpose of the issue (If issued as consideration for the acquisition of assets, clearly identify those assets) Issue options to employees under company s Global Employee Share Option Plan
7 Dates of entering + securities into uncertificated holdings or despatch of certificates 1 st August 2012
Number +Class
8 Number and + class of all + securities quoted on ASX ( including the securities in clause 2 if applicable) 1,066,063,388 Ordinary fully paid shares (PRR)
+ See chapter 19 for defined terms.
Number +Class Options
9 Number and + class of all + securities not quoted on ASX ( including the securities in clause 2 if applicable) Amount Exercise Price Expiration Date ASX Code
1,884,253 $ 0.2685 9 November 2014 PRRAS
1,884,253 $ 0.2360 8 December 2014 PRRAU
1,061,411 $ 0.2271 12 January 2015 PRRAY
1,118,211 $ 0.2345 12 February 2015 PRRAW
1,075,269 $ 0.2277 18 March 2015 PRRAZ
500,000 $ 0.2500 6 May 2015 PRRAC
1,055,011 $ 0.2351 19 May 2015 PRRAD
32,500,000 $ 0.2000 6 December 2013 PRRAL
2,000,000 $ 0.1000 6 December 2014 PRRAL
500,000 $ 0.1000 26 August 2014 PRRAL
740,741 $ 0.3390 1 February 2016 PRRAL
100,000 $ 0.2790 3 November 2014 PRRAL
100,000 $ 0.2329 3 January 2015 PRRAL
1,600,000 $ 0.1850 1 August 2015 PRRAL
46,119,149 Total
10 Dividend policy (in the case of a trust, distribution policy) on the increased capital (interests) Unchanged
+ See chapter 19 for defined terms.
Part 2 - Bonus Issue or Pro Rata Issue
11 Is security holder approval required?
12 Is the issue renounceable or non-renounceable?
13 Ratio in which the + securities will be offered
14 + Class of + securities to which the offer relates
15 + Record date to determine entitlements
16 Will holdings on different registers (or subregisters) be aggregated for calculating entitlements?
17 Policy for deciding entitlements in relation to fractions
18 Names of countries in which the entity has + security holders who will not be sent new issue documents Note: Security holders must be told how their entitlements are to be dealt with. Cross reference: rule 7.7.
19 Closing date for receipt of acceptances or renunciations
20 Names of any underwriters
21 Amount of any underwriting fee or commission
22 Names of any brokers to the issue
23 Fee or commission payable to the broker to the issue
24 Amount of any handling fee payable to brokers who lodge acceptances or renunciations on behalf of + security holders
+ See chapter 19 for defined terms.
25 If the issue is contingent on + security holders approval, the date of the meeting
26 Date entitlement and acceptance form and prospectus or Product Disclosure Statement will be sent to persons entitled
27 If the entity has issued options, and the terms entitle option holders to participate on exercise, the date on which notices will be sent to option holders
28 Date rights trading will begin (if applicable)
29 Date rights trading will end (if applicable)
30 How do + security holders sell their entitlements in full through a broker?
31 How do + security holders sell part of their entitlements through a broker and accept for the balance?
32 How do + security holders dispose of their entitlements (except by sale through a broker)?
33 + Despatch date
Part 3 - Quotation of Securities
You need only complete this section if you are applying for quotation of securities
34 Type of securities (tick one)
(a) Securities described in Part 1
(b) All other securities Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities
+ See chapter 19 for defined terms.
Entities that have ticked box 34(a)
Additional securities forming a new class of securities
Tick to indicate you are
providing the information or documents
35 If the + securities are + equity securities, the names of the 20 largest holders of the additional + securities, and the number and percentage of additional + securities held by those holders
36 If the + securities are + equity securities, a distribution schedule of the additional + securities setting out the number of holders in the categories 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001 and over
37 A copy of any trust deed for the additional + securities
Entities that have ticked box 34(b)
38 Number of securities for which + quotation is sought
39 Class of + securities for which quotation is sought
40 Do the + securities rank equally in all respects from the date of allotment with an existing + class of quoted + securities? If the additional securities do not rank equally, please state: the date from which they do the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment
41 Reason for request for quotation now Example: In the case of restricted securities, end of restriction period (if issued upon conversion of another security, clearly identify that other security)
Number + Class
42 Number and + class of all + securities quoted on ASX ( including the securities in clause 38)
+ See chapter 19 for defined terms.
entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty
Sign Here:
Company Secretary Date: Monday, 14 th August 2012
Print Name: Ian Bangs
+ See chapter 19 for defined terms.
Last updated: Aug 16, 2012